{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:26:03Z","timestamp":1774916763718,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":339,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1002\/rth2.12648","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T01:49:55Z","timestamp":1642988995000},"page":"e12648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Direct oral anticoagulants\u2010Remove versus Taipan snake venom time for detection of a lupus anticoagulant in patients taking oral direct factor Xa inhibitors"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7711-6875","authenticated-orcid":false,"given":"Danielle","family":"White","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary W.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Besser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8740-0194","authenticated-orcid":false,"given":"Will","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/rth2.12648_bb0010","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/rth2.12222","article-title":"Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017","volume":"3","author":"Lutsey","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"issue":"2","key":"10.1002\/rth2.12648_bb0015","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/bjh.16431","article-title":"What is the appropriate anticoagulation strategy for thrombotic antiphospholipid syndrome?","volume":"189","author":"Arachchillage","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1002\/rth2.12648_bb0020","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1111\/jth.14935","article-title":"Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the scientific and standardization committee of the international society on thrombosis and haemostasis","volume":"18","author":"Zuily","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12648_bb0025","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/bjh.12975","article-title":"Measurement of non\u2010Coumarin anticoagulants and their effects on tests of haemostasis: Guidance from the British committee for standards in haematology","volume":"166","author":"Kitchen","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1002\/rth2.12648_bb0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/jth.13912","article-title":"Laboratory testing in patients treated with direct oral anticoagulants: A practical guide for clinicians","volume":"16","author":"Douxfils","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12648_bb0035","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/jth.14846","article-title":"Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis","volume":"18","author":"Tripodi","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12648_bb0040","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/jth.15047","article-title":"Guidance from the Scientific and Standardisation Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis. Update of the guidelines for lupus anticoagulant detection and interpretation","volume":"18","author":"Devreese","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"Suppl. 1","key":"10.1002\/rth2.12648_bb0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/ijlh.13196","article-title":"The effect of DOACs on laboratory tests and their removal by activated carbon to limit interference in functional assays","volume":"42","author":"Exner","year":"2020","journal-title":"Int J Lab Hematol"},{"key":"10.1002\/rth2.12648_bb0050","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/ijlh.13267","article-title":"Evaluation of DOAC Filter, a new device to remove direct oral anticoagulants from plasma samples","volume":"42","author":"Sevenet","year":"2020","journal-title":"Int J Lab Hematol"},{"key":"10.1002\/rth2.12648_bb0055","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1111\/ijlh.12611","article-title":"The Taipan snake venom time can be used to detect lupus anticoagulant in patients treated by rivaroxaban","volume":"39","author":"Pouplard","year":"2017","journal-title":"Int J Lab Hematol"},{"key":"10.1002\/rth2.12648_bb0060","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/bjh.16308","article-title":"Addendum to British Society for Haematology Guidelines on Investigation and Management of Antiphospholipid syndrome, 2012 (Br. J. Haematol. 2012;157:47\u201058): Use of direct acting oral anticoagulants","volume":"189","author":"Arachchillage","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1002\/rth2.12648_bb0065","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/bjh.16091","article-title":"A diagnostic solution for haemostasis laboratories for patients taking direct oral anticoagulants using DOAC\u2010Remove","volume":"187","author":"Cox\u2010Morton","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1002\/rth2.12648_bb0070","author":"Moore","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12648_bb0075","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Laboratory Testing for the Lupus Anticoagulant: Approved Guideline; CLSI Document H60\u2010A; Clinical and Laboratory Standards Institute. Wayne, PA, USA, 2014."},{"key":"10.1002\/rth2.12648_bb0080","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1111\/jth.14894","article-title":"Direct oral anticoagulant adsorption: Impact on lupus anticoagulant testing\u2010Review of the literature and evaluation on spiked and patient samples","volume":"18","author":"De Kesel","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"8","key":"10.1002\/rth2.12648_bb0085","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/jth.14488","article-title":"Resolving DOAC interference on aPTT, PT, and lupus anticoagulant testing by the use of activated carbon","volume":"17","author":"Frans","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12648_bb0090","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.thromres.2019.11.001","article-title":"Potential usefulness of activated charcoal (DOAC remove\u00ae) for dRVVT testing in patients receiving Direct Oral AntiCoagulants","volume":"184","author":"Jourdi","year":"2019","journal-title":"Thromb Res"},{"key":"10.1002\/rth2.12648_bb0095","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/jth.12917","article-title":"Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome","volume":"13","author":"Arachchillage","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1002\/rth2.12648_bb0100","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/MBC.0000000000000247","article-title":"Rivaroxaban use in patients with antiphospholipid syndrome and previous venous thromboembolism","volume":"26","author":"Sciascia","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1002\/rth2.12648_bb0105","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/j.1538-7836.2011.04395.x","article-title":"Detection of lupus anticoagulant in the presence of rivaroxaban using Taipan snake venom time","volume":"9","author":"van Os","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12648_bb0110","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/ced.14229","article-title":"Taipan snake venom time for antiphospholipid syndrome solves a 20\u2010year diagnostic challenge","volume":"45","author":"Cunliffe","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"10.1002\/rth2.12648_bb0115","series-title":"User protocol for evaluation of qualitative test performance; approved guideline","year":"2008"},{"issue":"4","key":"10.1002\/rth2.12648_bb0120","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1515\/cclm-2019-1248","article-title":"Mixing studies for lupus anticoagulant: Mostly no, sometimes yes","volume":"58","author":"Moore","year":"2020","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"10.1002\/rth2.12648_bb0125","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1515\/cclm-2019-1240","article-title":"Mixing studies for lupus anticoagulant: Mostly yes, sometimes no","volume":"58","author":"Favaloro","year":"2020","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"10.1002\/rth2.12648_bb0130","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-0038-1627480","article-title":"International council for standardization in haematology (ICSH) recommendations for laboratory measurement of direct oral anticoagulants","volume":"118","author":"Gosselin","year":"2018","journal-title":"Thromb Haemost"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12648","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/rth2.12648","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922011116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922011116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12648","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:23:02Z","timestamp":1762863782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037922011116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2475037922011116"],"URL":"https:\/\/doi.org\/10.1002\/rth2.12648","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct oral anticoagulants\u2010Remove versus Taipan snake venom time for detection of a lupus anticoagulant in patients taking oral direct factor Xa inhibitors","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/rth2.12648","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The Authors. Research and Practice in Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}],"article-number":"e12648"}}